Scherbakov A M

30PUBLICATIONS
71CO-AUTHORS
Molecular targetsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Dec 30, 2025
Secosteroid-2-Pyrazoline Hybrids: Design, Synthesis, Biological Evaluation and Development of Therapeutic Combinations Against ERα-Positive Breast Cancer Cells.

Alexey I Ilovaisky, Alexander M Scherbakov, Fedor B Bogdanov

|Dec 17, 2025
Continuous Uptake of MiR-181a-2 Mimetic Induces Constitutive Overexpression of Cellular MiR-181a-2 in MCF-7 Breast Cancer Cells: Links with Progression of Drug Resistance.

Olga Evgen'evna Andreeva, Danila Vladimirovich Sorokin, Svetlana Vladimirovna Vinokurova

|Apr 14, 2025
Novel <i>N</i>-(4,5,6,7-tetrahydrobenzisoxazol-4-yl)amides as HSP90 inhibitors: design, synthesis and biological evaluation.

Nastassia A Varabyeva, Alexander M Scherbakov, Diana I Salnikova

|Mar 21, 2025
Prognostic value of progesterone receptor expression in non-small cell lung cancer tissue.

Romanov I P, Bogush T A, Scherbakov A M

|Jul 24, 2024
Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1,4-dioxides as carbonic anhydrase inhibitors.

Galina I Buravchenko, Alexander M Scherbakov, Stepan K Krymov

|Jul 19, 2024
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells.

Yulia Volkova, Alexander Scherbakov, Yaraslau Dzichenka

Pageof 5

Frequent Collaborators

9 joint publications

Diana Salnikova

6 joint publications

Andrey E Shchekotikhin

6 joint publications

Olga Evgen'evna Andreeva

5 joint publications

Fedor Bogdanov